Month: March 2021

Director of Partnerships

 JOB TITLE Director of Partnerships Full Time/Salaried $40,000/year + 10% Commission on New Business  POSITION OBJECTIVE To grow the awareness and support of Nonprofit Hub & Do More Good through meaningful partnerships that represent a win-win-win scenario:  Win #1 – The Nonprofit Hub audience receives innovative and thought-leadership-level content from trusted experts Win #2 – …

Director of Partnerships Read More »

Carl Bildt, former Prime Minister of Sweden, appointed WHO Special Envoy for the ACT-Accelerator

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, has appointed Mr Carl Bildt as WHO Special Envoy for the Access to COVID-19 Tools Accelerator (ACT-Accelerator). In his role as WHO Special Envoy for the ACT-Accelerator, Carl Bildt will help lead the collective advocacy for the ACT-Accelerator, mobilizing support and resources so it can deliver against its strategy …

Carl Bildt, former Prime Minister of Sweden, appointed WHO Special Envoy for the ACT-Accelerator Read More »

VSN membership

Currently the VSN has 95 member websites from all 6 WHO regions, from 42 countries, providing vaccine safety information in 36 languages. You are invited to visit the VSN portal and use the internal search engine to find reliable information on vaccine safety across all VSN members’ websites.

WHO calls for further studies, data on origin of SARS-CoV-2 virus, reiterates that all hypotheses remain open

The report of the international team on their Wuhan field visit, from 14 January -10 February 2021, was published today as WHO Director-General Dr Tedros Adhanom Ghebreyesus called for further studies. The report stems from a Member State resolution adopted by consensus at the World Health Assembly in May 2020 and calling on WHO “to …

WHO calls for further studies, data on origin of SARS-CoV-2 virus, reiterates that all hypotheses remain open Read More »

Global leaders unite in urgent call for international pandemic treaty

25 heads of government and international agencies come together in extraordinary joint call New treaty would signal high-level political action needed to protect the world from future health crises The international community should work together “towards a new international treaty for pandemic preparedness and response” to build a more robust global health architecture that will …

Global leaders unite in urgent call for international pandemic treaty Read More »

Medical Product Alert N°2/2021: Falsified COVID-19 Vaccine BNT162b2

Alert Summary This WHO Medical Product Alert refers to falsified COVID-19 Vaccine identified as “BNT162b2” detected in Mexico in February 2021 and recently confirmed as falsified to the WHO. The falsified product was supplied and administered to patients outside authorized vaccination programs. This falsified COVID-19 Vaccine may still be in circulation in the region and may …

Medical Product Alert N°2/2021: Falsified COVID-19 Vaccine BNT162b2 Read More »

Joint Statement on prioritization of COVID-19 vaccination for seafarers and aircrew

The coronavirus (COVID-19) pandemic has triggered devastating consequences for human life and the global economy. Maritime and air transport are two essential activities that underpin global trade and mobility and are key to a sustainable socio-economic recovery. More than 80% of global trade by volume is moved by maritime transport. The global economy depends on …

Joint Statement on prioritization of COVID-19 vaccination for seafarers and aircrew Read More »

COVAX updates participants on delivery delays for vaccines from Serum Institute of India (SII) and AstraZeneca

The COVAX Facility has notified participating economies that deliveries of doses from the Serum Institute of India (SII) will be delayed in March and April  Delays in securing supplies of SII-produced COVID-19 vaccine doses are due to the increased demand for COVID-19 vaccines in India Separately, participating economies in the COVAX Facility that have been …

COVAX updates participants on delivery delays for vaccines from Serum Institute of India (SII) and AstraZeneca Read More »